[ad_1] Eli Lilly ‘s raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little […]
Continue readingTag: Biogen Inc
Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
[ad_1] A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen […]
Continue reading